Clinical Trial Update: DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing DEB-TACE plus RALOX-HAIC versus DEB-TACE for large non-resectable hepatocellular carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DEB-TACE
• RALOX-HAIC

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: RECRUITING